A Randomized Controlled Comparative Study of Oral Medroxyprogesterone Acetate 1,200 and 600 mg in Patients with Advanced or Recurrent Breast Cancer

Publisher： Karger

E-ISSN： 1423-0232|56|4|283-290

ISSN： 0030-2414

Source： Oncology, Vol.56, Iss.4, 1999-05, pp. : 283-290

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Analysis of Serum Interleukin-6 Levels to Predict Benefits of Medroxyprogesterone Acetate in Advanced or Recurrent Breast Cancer

By  

Oncology, Vol. 59, Iss. 2, 2000-08 ,pp. : 166-173

Karger

Access to resources Recommend Favorite

Carboplatin, Methotrexate and 5-Fluorouracil in Combination with Medroxyprogesterone Acetate (JMF-M) in the Treatment of Advanced or Recurrent Endometrial Carcinoma: A Hellenic Cooperative Oncology Group Study

By  

Oncology, Vol. 56, Iss. 3, 1999-04 ,pp. : 198-201

Karger

Access to resources Recommend Favorite

Anions in Acetate‐Free Biofiltration

By  

THERAPEUTIC APHERESIS AND DIALYSIS, Vol. 19, Iss. 1, 2015-02 ,pp. : 63-72

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prospective, Double-Blind, Placebo-Controlled, Multicenter, Randomized Phase III Study with Orally Administered Budesonide for Prevention of Irinotecan (CPT-11)-Induced Diarrhea in Patients with Advanced Colorectal Cancer

By  

Oncology, Vol. 68, Iss. 4-6, 2005-08 ,pp. : 326-332

Karger

Access to resources Recommend Favorite

Effects of resistance exercise on fatigue and quality of life in breast cancer patients undergoing adjuvant chemotherapy: A randomized controlled trial

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 2, 2015-07 ,pp. : 471-480

John Wiley & Sons Inc

Access to resources Recommend Favorite